Palatin Technologies

Innovating melanocortin therapeutics for inflammatory, autoimmune, and ocular diseases

placeCranbury, New Jersey, United States calendar_todayFounded 1996 groups34 employees language palatin.com

Registered entities

Social engagement

Social engagement: 2.5K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital267%
Private equity133%

Recent activity

6 Nov 2025
Event
ObesityWeek® 2025
Coming soon